Verywell Health on MSN4mon
4 Types of Biologics Used for Ulcerative Colitis
Medically reviewed by Mary Choy, PharmD Biologics work by targeting proteins that cause inflammation in ulcerative colitis.
GlobalData on MSN3d
J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis
The request is based on findings from the Phase III ASTRO study, which achieved the primary endpoint of clinical remission at ...
Daily3d
Icotrokinra shows impressive results in moderate to severe plaque psoriasis in phase 3 trial
Icotrokinra is an investigational oral peptide that blocks interleukin (IL)-23 receptor, which plays a significant role in ...
clinicaladvisor.com11d
New Presentation, Indications Approved for Biosimilar Selarsdi
The Food and Drug Administration (FDA) has approved a new presentation of Selarsdi ™ (ustekinumab-aekn), a biosimilar to Stelara ® (ustekinumab), expanding the product’s indications to include ...
biopharma-reporter5d
Phase 3 win for Protagonist Therapeutics with oral plaque psoriasis drug
The promising trial results put icotrokinra on track to fulfill its potential as a best in class oral therapeutic for the ...